Claris Bio is a startup based in the United States, 1 tracked investor.
Based in the United States, Claris Bio is a startup. Brouky records 1 investor associated with the company.
Claris Bio develops novel biologic therapies for corneal diseases, focusing on restoring corneal integrity with their lead topical ocular biologic dHGF for Limbal Stem Cell Deficiency (LSCD).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.